Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06665594
PHASE2

Effect of TXA on Reducing Bruising After Filler Injection

Sponsor: University of Wisconsin, Madison

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.

Official title: Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study

Key Details

Gender

All

Age Range

18 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-12-05

Completion Date

2026-11

Last Updated

2026-02-03

Healthy Volunteers

Yes

Interventions

PROCEDURE

Hyaluronic Acid (HA)

Injectable gel

DRUG

Tranexamic Acid (TXA)

Injection of TXA

DRUG

Saline (placebo)

Injection of saline

Locations (1)

University of Wisconsin - Madison

Madison, Wisconsin, United States